Comprehensive analysis of DSP Value Fund (G) (41749) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
DSP Investment Managers Private Ltd
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities which are currently undervalued. However, there is no assurance that the investment objective of the scheme will be realized.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Moderate Returns
High Risk
Moderate Expenses
Balanced Mix
Established Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Outperformance vs benchmark
Historical performance consistency
Recent performance momentum
Market exposure level
Fund manager experience
Risk-adjusted returns
Assets under management
Fund management costs
This fund has outperformed its benchmark by 3.20% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| HDFC Bank Ltd | Banks | 8.30% |
| Harding Loevner Global Equity Fund | Debt Others | 5.54% |
| Net CA & Others | Debt Others | 5.27% |
| Larsen & Toubro Ltd | Infrastructure Developers & Operators | 2.84% |
| Infosys Ltd | IT - Software | 2.77% |
| WCM GLOBAL EQUITY FUND | Debt Others | 2.63% |
| Microsoft Corp | Debt Others | 2.28% |
| Bharat Electronics Ltd | Aerospace & Defence | 2.18% |
| Cipla Ltd | Pharmaceuticals | 2.10% |
| Dr Reddys Laboratories Ltd | Pharmaceuticals | 2.10% |
Compare against Value Fund category average
This comparison shows how the fund performs relative to the Value Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Value Fund category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| HDFC Value Fund - Direct (G) | ₹814.17 | 16.44% | -1.55% | 19.92% |
| Templeton India Value Fund - Direct (G) | ₹783.91 | 12.52% | -6.63% | 19.09% |
| HDFC Value Fund - Regular (G) | ₹728.17 | 15.97% | -2.36% | 18.90% |
| Templeton India Value Fund - (G) | ₹701.76 | 11.85% | -7.73% | 17.67% |
| ICICI Pru Value Fund - Direct (G) | ₹515.36 | 14.06% | 0.67% | 22.36% |
| ICICI Pru Value Fund (G) | ₹468.69 | 13.76% | 0.15% | 21.72% |
| Tata Value Fund - Direct (G) | ₹382.98 | 13.89% | -8.61% | 19.52% |
| Tata Value Fund - (G) | ₹339.65 | 13.32% | -9.50% | 18.35% |
| Nippon India Value Fund - Direct (G) | ₹244.05 | 14.00% | -2.97% | 22.03% |
| Nippon India Value Fund (G) | ₹222.70 | 13.58% | -3.67% | 21.16% |
A seasoned investment professional with over 5 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.